| Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants (NCT00617071) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2007-01-01 |
| Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer (NCT00675636) | Vanderbilt University Medical Center | 2007-01-01 |
| Information Needs After Surgery for Colorectal Cancer (NCT01303393) | Region Skane | 2007-01-01 |
| Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy (NCT00897403) | Vanderbilt University | 2006-12-01 |
| Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer (NCT00394992) | Dutch Colorectal Cancer Group | 2006-12-01 |
| Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC (NCT00469443) | Hellenic Oncology Research Group | 2006-12-01 |
| Collection of Patient-Reported Symptoms and Performance Status Via the Internet (NCT00417040) | Alliance for Clinical Trials in Oncology | 2006-12-01 |
| A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer (NCT00483834) | University Health Network, Toronto | 2006-12-01 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer (NCT00436410) | National Institutes of Health Clinical Center (CC) | 2006-12-01 |
| Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy (NCT00419159) | Novartis Pharmaceuticals | 2006-12-01 |
| Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil (NCT00389870) | University of Leeds | 2006-12-01 |
| Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer (NCT01254591) | University College London (UCL) Cancer Institute | 2006-11-01 |
| SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial (NCT00418938) | Amgen | 2006-11-01 |
| Immunoreactivity to Cetuximab in Cancer Patients (NCT00896896) | Vanderbilt-Ingram Cancer Center | 2006-11-01 |
| S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer (NCT00118105) | SWOG Cancer Research Network | 2006-11-01 |
| Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers (NCT00410579) | NSABP Foundation Inc | 2006-11-01 |
| A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. (NCT01135498) | Hoffmann-La Roche | 2006-11-01 |
| Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-11-01 |
| Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment (NCT00411450) | Amgen | 2006-11-01 |
| A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES) (NCT00388206) | Genentech, Inc. | 2006-11-01 |
| Reducing Cancer Disparities for American Indians in the Rural Intermountain West (NCT00380055) | University of Utah | 2006-10-01 |
| A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer (NCT00388700) | Galectin Therapeutics Inc. | 2006-10-01 |
| Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project (NCT00379782) | Queen's Medical Center | 2006-10-01 |
| A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer (NCT00601198) | University of Cincinnati | 2006-10-01 |
| Case Volume and Adenoma Rate During Screening Colonoscopy (NCT00860665) | Charite University, Berlin, Germany | 2006-10-01 |
| Probiotics In Colorectal Cancer Patients (NCT00936572) | University of Milano Bicocca | 2006-10-01 |
| Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery (NCT00392899) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2006-10-01 |
| Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery (NCT00544349) | Gustave Roussy, Cancer Campus, Grand Paris | 2006-10-01 |
| Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery (NCT00898846) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2006-10-01 |
| Colon Investigation - Factors Determining Choice of Procedure (NCT00423345) | Sykehuset Telemark | 2006-10-01 |
| Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy (NCT00390364) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-10-01 |
| Colorectal Inflammatory Response to a Western-Style Diet (NCT00932308) | Rockefeller University | 2006-09-01 |
| Tumour Registry Colorectal Cancer (NCT00910819) | iOMEDICO AG | 2006-09-01 |
| Cholecalciferol and Calcium Carbonate in Treating Patients With Colon Cancer That Has Been Removed by Surgery (NCT00470353) | Roswell Park Cancer Institute | 2006-09-01 |
| First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX (NCT00384176) | AstraZeneca | 2006-08-30 |
| FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer (NCT00724503) | Sirtex Medical | 2006-08-01 |
| 131-I-TM-601 Study in Adults With Solid Tumors (NCT00379132) | TransMolecular | 2006-08-01 |
| Non-Invasive Prediction of Colorectal Neoplasia (NCT01815463) | Corporal Michael J. Crescenz VA Medical Center | 2006-08-01 |
| Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer (NCT00496509) | Genzyme, a Sanofi Company | 2006-08-01 |
| A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. (NCT00349336) | Hoffmann-La Roche | 2006-08-01 |
| A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies (NCT00441337) | Bristol-Myers Squibb | 2006-08-01 |
| Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer (NCT00392470) | Centre Hospitalier Universitaire Vaudois | 2006-08-01 |
| Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study (NCT00285701) | Photocure | 2006-07-01 |
| Ambulatory Cancer Pain Management: A Feasibility Study (NCT00507351) | M.D. Anderson Cancer Center | 2006-07-01 |
| Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer (NCT00331786) | Stony Brook University | 2006-07-01 |
| A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer (NCT00671372) | Genentech, Inc. | 2006-07-01 |
| Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients (NCT00335595) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2006-07-01 |
| Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00303745) | Federation Francophone de Cancerologie Digestive | 2006-06-01 |
| Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX (NCT00381862) | OHSU Knight Cancer Institute | 2006-06-01 |
| Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer (NCT00336141) | University of Southern California | 2006-06-01 |
| A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum. (NCT01169558) | Hoffmann-La Roche | 2006-05-01 |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer (NCT00114231) | Alliance for Clinical Trials in Oncology | 2006-05-01 |
| Phase II Trial of RAD001 in Refractory Colorectal Cancer (NCT00337545) | Swedish Medical Center | 2006-05-01 |
| Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases (NCT00327093) | Hospices Civils de Lyon | 2006-05-01 |
| FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer (NCT00323011) | University of Southern California | 2006-05-01 |
| Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer (NCT00647153) | City of Hope Medical Center | 2006-05-01 |
| Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer (NCT00372840) | Fox Chase Cancer Center | 2006-05-01 |
| A Multicenter Study on the Safety and Functionality Evaluation of Anastomotic Redo Surgery (NCT07279961) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2006-05-01 |
| Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy (NCT00332163) | Amgen | 2006-04-01 |
| First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients (NCT00251186) | University of Medicine and Dentistry of New Jersey | 2006-04-01 |
| A Study of Picoplatin in Colorectal Cancer (NCT00478946) | Poniard Pharmaceuticals | 2006-04-01 |
| Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer (NCT02289053) | University of Michigan | 2006-04-01 |
| Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer (NCT00325871) | Mackay Memorial Hospital | 2006-04-01 |
| Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (NCT00423696) | UNICANCER | 2006-03-23 |
| Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer (NCT00303914) | Eastern Cooperative Oncology Group | 2006-03-14 |
| Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases (NCT00264979) | Rennes University Hospital | 2006-03-02 |
| Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer (NCT00203411) | Translational Oncology Research International | 2006-03-01 |
| A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer (NCT00385970) | Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group | 2006-03-01 |
| Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors (NCT00335491) | University of Utah | 2006-03-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery (NCT00321828) | NSABP Foundation Inc | 2006-03-01 |
| Assessment of Frequency of Surveillance After Curative Resection in Patients With Stage II and III Colorectal Cancer (NCT00225641) | Bispebjerg Hospital | 2006-03-01 |
| Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer (NCT00387348) | Massachusetts General Hospital | 2006-03-01 |
| Magnetic Resonance (MR) Colonography With Fecal Tagging (NCT00114842) | Herlev Hospital | 2006-03-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer (NCT00449163) | University of Miami | 2006-03-01 |
| 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer (NCT00308516) | SCRI Development Innovations, LLC | 2006-03-01 |
| Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer (NCT00296062) | Case Comprehensive Cancer Center | 2006-03-01 |
| Study of Gamma Interfereon in Metastatic Colorectal Carcinoma (NCT00786643) | Accelerated Community Oncology Research Network | 2006-02-01 |
| MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer (NCT00602329) | Abramson Cancer Center at Penn Medicine | 2006-02-01 |
| Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer (NCT00345761) | Chugai Pharmaceutical | 2006-02-01 |
| A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. (NCT00700102) | Hoffmann-La Roche | 2006-02-01 |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors (NCT00369109) | Barbara Ann Karmanos Cancer Institute | 2006-02-01 |
| Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy (NCT00442520) | University of Kansas Medical Center | 2006-02-01 |
| A Phase I Study of ECO-4601 in Patients With Advanced Cancer (NCT00338026) | Thallion Pharmaceuticals | 2006-02-01 |
| Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer (NCT00305643) | M.D. Anderson Cancer Center | 2006-02-01 |
| BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies (NCT00207051) | Bristol-Myers Squibb | 2006-01-01 |
| Colorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy (NCT01075633) | Enrique Quintero | 2006-01-01 |
| Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) (NCT00278889) | AstraZeneca | 2006-01-01 |
| Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer (NCT00311610) | Alliance for Clinical Trials in Oncology | 2006-01-01 |
| Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer (NCT00284258) | Taiho Pharmaceutical Co., Ltd. | 2006-01-01 |
| Molecular Profiling of Colorectal Cancer (NCT04863768) | Hellenic Cooperative Oncology Group | 2006-01-01 |
| Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery (NCT00316914) | Alliance for Clinical Trials in Oncology | 2006-01-01 |
| Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery (NCT00290615) | Herbert Hurwitz | 2006-01-01 |
| A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. (NCT01159171) | Hoffmann-La Roche | 2006-01-01 |
| Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer (NCT00268463) | NSABP Foundation Inc | 2006-01-01 |
| Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer (NCT00648102) | Celldex Therapeutics | 2006-01-01 |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer (NCT00897793) | Vanderbilt-Ingram Cancer Center | 2006-01-01 |
| A Study of Mitomycin C, Irinotecan, and Cetuximab (NCT00271011) | University of Michigan Rogel Cancer Center | 2005-12-01 |
| Study of XL999 in Patients With Metastatic Colorectal Cancer (NCT00277303) | Symphony Evolution, Inc. | 2005-12-01 |
| Trial of a Multilevel Intervention to Increase Colorectal Cancer Screening (NCT00836303) | NYU Langone Health | 2005-12-01 |
| MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil (NCT00332943) | Herlev Hospital | 2005-12-01 |